A detailed history of Quest Partners LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 8,607 shares of FLGT stock, worth $145,888. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,607
Previous 17,786 51.61%
Holding current value
$145,888
Previous $349 Million 46.4%
% of portfolio
0.02%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$19.6 - $25.06 $179,908 - $230,025
-9,179 Reduced 51.61%
8,607 $187 Million
Q2 2024

Aug 06, 2024

BUY
$19.09 - $22.57 $338,236 - $399,895
17,718 Added 26055.88%
17,786 $349 Million
Q1 2024

May 09, 2024

BUY
$21.55 - $29.29 $1,465 - $1,991
68 New
68 $1.48 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $513M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.